These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23939522)

  • 1. Does managed problem solving work and in what setting?
    de Bruin M
    JAMA Intern Med; 2013 Aug; 173(15):1474. PubMed ID: 23939522
    [No Abstract]   [Full Text] [Related]  

  • 2. Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence".
    Bangsberg DR; Haberer JE
    JAMA Intern Med; 2013 Feb; 173(4):306-7. PubMed ID: 23358810
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: To PMID 23358784.
    Gross R; Bellamy SL; Strom BL
    JAMA Intern Med; 2013 Aug; 173(15):1475-6. PubMed ID: 23939524
    [No Abstract]   [Full Text] [Related]  

  • 4. Managed problem solving for antiretroviral therapy adherence: a randomized trial.
    Gross R; Bellamy SL; Chapman J; Han X; O'Duor J; Palmer SC; Houts PS; Coyne JC; Strom BL
    JAMA Intern Med; 2013 Feb; 173(4):300-6. PubMed ID: 23358784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quest for an effective adherence intervention: a DOT-cART case study.
    Athey E
    J Assoc Nurses AIDS Care; 2014; 25(6):682-6. PubMed ID: 25305032
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods.
    Marcellin F; Spire B; Carrieri MP; Roux P
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):239-50. PubMed ID: 23458765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unlocking adherence: is gender the key?
    Puskas C; Hogg RS
    Lancet HIV; 2015 Jan; 2(1):e2-3. PubMed ID: 26424233
    [No Abstract]   [Full Text] [Related]  

  • 8. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
    Wepner U
    MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving adherence to antiretroviral therapy.
    Daar ES; Cohen C; Remien R; Sherer R; Smith K
    AIDS Read; 2003 Feb; 13(2):81-2, 85-6, 88-90. PubMed ID: 12645492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on: Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database.
    Grammatico-Guillon L; Gras G; Hassen-Khodja C; Maakaroun Z; Bastides F; Barin F; Bernard L
    J Antimicrob Chemother; 2015 Nov; 70(11):3172-3. PubMed ID: 26253090
    [No Abstract]   [Full Text] [Related]  

  • 11. A digital picture is worth a thousand words in a different dialect: improving adherence to antiretroviral medication.
    Bryant PA; Bordun L; Connell TG
    Arch Dis Child; 2013 Jun; 98(6):467. PubMed ID: 23661666
    [No Abstract]   [Full Text] [Related]  

  • 12. Adherence to antiretroviral therapy: supervision or support?
    Mills EJ; Lester R; Ford N
    Lancet Infect Dis; 2012 Feb; 12(2):97-8. PubMed ID: 22281134
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adherence to the antiretroviral treatment].
    Barreiro García P; González Lahoz J; Soriano Vázquez V
    Rev Clin Esp; 2003 Jun; 203(6):299-302. PubMed ID: 12783718
    [No Abstract]   [Full Text] [Related]  

  • 14. Retention among adults initiating antiretroviral therapy in South Africa: 2002-2007.
    Cornell M; Grimsrud A; Boulle A; Myer L
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):e102; author reply e102-3. PubMed ID: 21317578
    [No Abstract]   [Full Text] [Related]  

  • 15. Short course directly observed therapy to monitor compliance with antiretroviral therapy in human immunodeficiency virus-infected children.
    Gigliotti F; Murante BL; Weinberg GA
    Pediatr Infect Dis J; 2001 Jul; 20(7):716-8. PubMed ID: 11465849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Securing opioid substitution treatment access and quality for people who inject drugs.
    Carrieri MP; Sagaon-Teyssier L; Roux P
    AIDS; 2015 May; 29(8):975-6. PubMed ID: 25909829
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful integrase inhibitor-based highly active antiretroviral therapy for a multidrug-class-resistant HIV type 1 group O-infected patient in Cameroon.
    Aghokeng AF; Kouanfack C; Peeters M; Mpoudi-Ngole E; Delaporte E
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):1-3. PubMed ID: 22889147
    [No Abstract]   [Full Text] [Related]  

  • 18. [HIV therapy and adherence].
    Kuhlmann B
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():62-3. PubMed ID: 19024920
    [No Abstract]   [Full Text] [Related]  

  • 19. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
    Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
    AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.